Image

Stress Management Toolkit for People Living With Dementia and Their Care Partners

Stress Management Toolkit for People Living With Dementia and Their Care Partners

Non Recruiting
21 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to develop a prototype of a home-based, dyadic tangible toolkit comprised of simple tools to help people living with dementia (PLWD) and their care partners manage stress at home.

A human-centered design approach will be used to develop and user-test a prototype of a dyadic, tangible stress-management toolkit with and for PLWD and their care partners; and to explore the feasibility of collecting several stress-related outcomes. A total of 4 focus groups (n=3-4 dyads/group) will be convened to explore the experiences, perceptions, preferences, and recommendations of dementia-caring dyads regarding stress, stress management, and key components and features of a stress management toolkit. Eligible tools for the toolkit include low burden, high safety tools such as weighted blankets, robotic pets and baby dolls, guided journals, aromatherapy and bright light therapy devices, and massage and acupressure tools. Ten dyads who were not involved in prototype development will then use the toolkit for 2 weeks. Feedback on usability, feasibility, and acceptability will be collected through questionnaires (end of weeks 1 and 2) and 3 focus groups (3-4 dyads/group at end of week 2). We will collect stress-related, participant-reported outcomes (e.g., neuropsychiatric symptoms of dementia, caregiver stress, dyadic relationship strain), and saliva biospecimens from participants with dementia and their care partners at baseline and end of week 2, to explore their utility as endpoints in a future toolkit intervention that uses a single-arm, pre-post study design. Results will yield valuable data to support development and preliminary testing of a stress management toolkit intervention in a future pilot study.

This study involves human subjects and is expected to yield no more than minimal risk. Tools eligible for the toolkit must have demonstrated high degrees of safety in prior research. Major risks for participation include the potential for negative emotional responses to focus group discussions and surveys pertaining to stress, excess time burden to participate in the study, and breach of confidentiality. It is not anticipated, but there is a potential for physical discomfort if tools are not used as directed, which is why the toolkits will include a user guide outlining safety information, which a research team member will review with each participant prior to use.

Eligibility

Inclusion criteria for participants with dementia are:

  • age 60 years and over with a diagnosis of dementia of any type
  • able to express self verbally
  • English speaking.

Exclusion criteria for participants with dementia is:

        • has a hearing or visual impairment that limits their ability to participate in the
        screening process or to participate in a focus group.
        Inclusion criteria for care partner participants are:
          -  age 21 years and older
          -  identify as a primary care partner of someone with dementia
          -  English speaking
        Exclusion criteria for care partner participants is:
        • has a hearing or visual impairment that limits their ability to participate in the
        screening process or to participate in a focus group.
        Dyadic eligibility criteria include:
          -  both the PLWD and care partner reside in the same household or personal residence in
             the community
          -  dyad has lived together for at least 1 month
          -  dyad has telephone or internet access
          -  Dyads will be excluded if they reside in assisted living or other long-term care
             setting.
        Dyads participating in user-testing phase will also be excluded if either member:
          -  currently receives cytokine-based therapy
          -  currently receives radiation therapy to the salivary glands or thyroid
          -  are diagnosed with Cushing or Addison's disease

Study details
    Dementia
    Stress
    Caregiver Burden

NCT05465551

Duke University

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.